HICOR Leadership



Dr. Scott Ramsey

Scott Ramsey, M.D., Ph.D.

HICOR Director

Dr. Ramsey is one of only a handful of doctors worldwide who are also health economists. He has led landmark studies on patterns of care and the costs and cost-effectiveness of treatments for lung, colorectal and prostate cancer. A practicing physician, he leads clinical trials through the Bone Marrow Transplant Clinical Trials Network as well as pragmatic trials evaluating health care delivery interventions through SWOG Cancer Research Network.

Professor, Cancer Prevention Program, Public Health Sciences Division, Fred Hutch
Adjunct Professor, Department of Health Services, University of Washington
Professor of Medicine, Division of General Internal Medicine, University of Washington
Adjunct Professor, Pharmaceutical Outcomes, Research, and Policy Program; Department of Pharmacy, University of Washington

Dr. Veena Shankaran

Veena Shankaran, M.D.

HICOR Co-Director

Dr. Shankaran is a gastrointestinal medical oncologist and health outcomes researcher who has devoted her research career to studying the financial challenges faced by cancer patients and caregivers. She has led several key studies demonstrating the serious financial impact that cancer treatment can have on patients. She also serves as the local principal investigator on a number of clinical trials in esophageal and gastric cancer. Shankaran has joint appointments at Fred Hutch, University of Washington School of Medicine and Seattle Cancer Care Alliance, where she has a busy clinical practice.

Professor, Clinical Research Division, Fred Hutch
Professor, Cancer Prevention Program, Public Health Sciences Division, Fred Hutch
Professor, School of Medicine, University of Washington

Judy Nelson

Judy Nelson

HICOR Director of Strategy

As director of strategy for HICOR, Judy Nelson is responsible for administrative and operational oversight, scientific portfolio management, strategic planning, executive leadership support, HICOR governance and oversight, and management of emerging scientific initiatives. She also leads program development activities and HICOR communications, promoting HICOR’s vision, mission and research priorities regionally and nationally.

Karma Kreizenbeck

Karma Kreizenbeck

HICOR Director of Research & Partnerships

As director of research and partnerships for HICOR, Karma Kreizenbeck oversees HICOR’s oncology performance reporting program and the Community Cancer Care Report. She also leads HICOR’s community engagement, managing a network of collaborating oncology clinics and developing partnerships with leaders in government, the health insurance industry and clinical, quality and policy organizations. In addition, she manages HICOR’s portfolio of collaborative research with technology partners, including Microsoft and Tableau.

External Advisory Board

Dr. Alan Balch

Alan J. Balch, Ph.D., M.S.

Chief Executive Officer, Patient Advocate Foundation and National Patient Advocate Foundation
Dr. Diana Brixner

Diana Brixner, Ph.D., R.Ph.

Chair, HICOR External Advisory Board
Professor, Department of Pharmacotherapy, University of Utah College of Pharmacy
Executive Director, Pharmacotherapy Outcomes Research Center, University of Utah
Director of Outcomes, Program in Personalized Health Care., University of Utah
Dr. Ethan Basch

Ethan Basch, M.D., M.Sc.

Richard M. Goldberg Distinguished Professor and Chief of Oncology , UNC School of Medicine
Physician-in-Chief, NC Cancer Hospital
Director of Cancer Outcomes Research, University of North Carolina
Dr. Maria Lopes

Maria Lopes, M.D., M.S.

Payer Strategy: Chief Medical Officer, CDMI/Magellan
Raymond Osarogiagbon, MBBS, FACP

Raymond Osarogiagbon, M.B.B.S., F.A.C.P.

Chief Scientist, Baptist Memorial Health Care
Director, Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research (ThOR) Group, Baptist Cancer Center in Memphis, Tennessee
Dr. Ya-Chen Tina Shih

Ya-Chen Tina Shih, Ph.D.

Director, Program in Cancer Health Economics Research, Jonsson Comprehensive Cancer Center
Professor of Health Economics, Department of Radiation Oncology, UCLA David Geffen School of Medicine



Dr. Jennifer Temel

Jennifer Temel, M.D.

Professor of Medicine, Harvard Medical School
Clinical Director Thoracic Oncology, Massachusetts General Hospital
Co-Director Cancer Outcomes Research and Education, Massachusetts General Hospital
Dr. Stephanie B. Wheeler

Stephanie B. Wheeler, Ph.D. M.P.H.

Michael S O’Malley Endowed Professor , University of North Carolina at Chapel Hill
Department of Health Policy & Management, Gillings School of Global Public Health
Associate Director of Community Outreach and Engagement, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Dr. Peter Yu

Peter Yu, M.D.

Physician-in-Chief, Hartford HealthCare Center Institute
Clinical Member, Memorial Sloan Kettering Cancer Center